Differential regulation of myofilament protein isoforms underlying the contractility changes in skeletal muscle unloading

Weight-bearing skeletal muscles change phenotype in response to unloading. Using the hindlimb suspension rat model, we investigated the regulation of myofilament protein isoforms in correlation to contractility. Four weeks of continuous hindlimb unloading produced progressive atrophy and contractility changes in soleus but not extensor digitorum longus muscle. The unloaded soleus muscle also had decreased fatigue resistance. Along with the decrease of myosin heavy chain isoform I and IIa and increase of IIb and IIx, coordinated regulation of thin filament regulatory protein isoforms were observed: - and -tropomyosin decreased and -tropomyosin increased, resulting in an / ratio similar to that in normal fast twitch skeletal muscle; troponin I and troponin T (TnT) both showed decrease in the slow isoform and increases in the fast isoform. The TnT isoform switching began after 7 days of unloading and TnI isoform showed detectable changes at 14 days while other protein isoform changes were not significant until 28 days of treatment. Correlating to the early changes in contractility, especially the resistance to fatigue, the early response of TnT isoform regulation may play a unique role in the adaptation of skeletal muscle to unloading. When the fast TnT gene expression was upregulated in the unloaded soleus muscle, alternative RNA splicing switched to produce more high molecular weight acidic isoforms, reflecting a potential compensation for the decrease of slow TnT that is critical to skeletal muscle function. The results demonstrate that differential regulation of TnT isoforms is a sensitive mechanism in muscle adaptation to functional demands. troponin T; fatigue resistance; troponin I; tropomyosin; myosin; hindlimb-suspended rat; Western blot protein quantification     

Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta

Muscle atrophy contributes to morbidity and mortality in aging and chronic disease, emphasizing the need to gain understanding of the mechanisms involved in muscle atrophy and (re)growth. We hypothesized that the magnitude of muscle regrowth during recovery from atrophy determines whether myonuclear accretion and myogenic differentiation are required and that insulin-like growth factor (IGF)-I/Akt/glycogen synthase kinase (GSK)-3 signaling differs between regrowth responses. To address this hypothesis we subjected mice to hindlimb suspension (HS) to induce atrophy of soleus (–40%) and plantaris (–27%) muscle. Reloading-induced muscle regrowth was complete after 14 days and involved an increase in IGF-IEa mRNA expression that coincided with Akt phosphorylation in both muscles. In contrast, phosphorylation and inactivation of GSK-3 were observed during soleus regrowth only. Furthermore, soleus but not plantaris regrowth involved muscle regeneration based on a transient increase in expression of histone 3.2 and myosin heavy chain-perinatal, which are markers of myoblast proliferation and differentiation, and a strong induction of muscle regulatory factor (MRF) expression. Experiments in cultured muscle cells showed that IGF-I-induced MRF expression is facilitated by inactivation of GSK-3 and selectively occurs in the myoblast population. This study suggests that induction of IGF-I expression and Akt phosphorylation during recovery from muscle atrophy is independent of the magnitude of muscle regrowth. Moreover, our data demonstrate for the first time that the regenerative response characterized by myoblast proliferation, differentiation, and increased MRF expression in recovering muscle is associated with the magnitude of regrowth and may be regulated by inactivation of GSK-3. glycogen synthase kinase-3; Akt; muscle growth; muscle atrophy     

Skeletal muscle adaptation in response to voluntary running in Ca2+/calmodulin-dependent protein kinase IV-deficient mice

Mammalian skeletal muscles undergo adaptation in response to alteration in functional demands by means of a variety of cellular signaling events. Previous experiments in transgenic mice showed that an active form of Ca²⁺/calmodulin-dependent protein kinase IV (CaMKIV) is capable of stimulating peroxisome proliferator-activated receptor -coactivator 1 (PGC-1) gene expression, promoting fast-to-slow fiber type switching and augmenting mitochondrial biogenesis in skeletal muscle. However, a role for endogenous CaMKIV in skeletal muscle has not been investigated rigorously. We report that genetically modified mice devoid of CaMKIV have normal fiber type composition and mitochondrial enzyme expression in fast-twitch skeletal muscles and responded to long-term (4 wk) voluntary running with increased expression of myosin heavy chain type IIa, myoglobin, PGC-1, and cytochrome c oxidase IV proteins in plantaris muscle in a manner similar to that of wild-type mice. Short-term motor nerve stimulation (2 h at 10 Hz) likewise increased PGC-1 mRNA expression in tibialis anterior muscles in both Camk4^–/– and wild-type mice. In addition, we have confirmed that no detectable CaMKIV protein is expressed in murine skeletal muscle. Thus CaMKIV is not required for the maintenance of slow-twitch muscle phenotype and endurance training-induced mitochondrial biogenesis and IIb-to-IIa fiber type switching in murine skeletal muscle. Other protein kinases sharing substrates with constitutively active CaMKIV may function as endogenous mediators of activity-dependent changes in myofiber phenotype. cellular signaling; proliferator-activated receptor -coactivator 1; fiber type switching; mitochondrial biogenesis     

Time-dependent changes in myosin heavy chain mRNA and protein isoforms in unloaded soleus muscle of rat

Time-dependent changes in myosin heavy chain(MHC) isoform expression were investigated in rat soleus muscleunloaded by hindlimb suspension. Changes at the mRNA level weremeasured by RT-PCR and correlated with changes in the pattern of MHCprotein isoforms. Protein analyses of whole muscle revealed that MHCIdecreased after 7 days, when MHCIIa had increased, reaching a transient maximum by 15 days. Longer periods led to inductions and progressive increases of MHCIId(x) and MHCIIb. mRNA analyses of whole muscle showedthat MHCIId(x) displayed the steepest increase after 4 days andcontinued to rise until 28 days, the longest time period investigated.MHCIIb mRNA followed a similar time course, although at lower levels.MHCI mRNA, present at extremely low levels in control soleus, peakedafter 4 days, stayed elevated until 15 days, and then decayed.Immunohistochemistry of 15-day unloaded muscles revealed that MHCIwas present in muscle spindles but at low amounts also in extrafusalfibers. The slow-to-fast transitions thus seem to proceed in the orderMHCI  MHCIIa  MHCIId(x)  MHCIIb. Ourfindings indicate that MHCI is transiently upregulated in somefibers as an intermediate step during the transition from MHCI to MHCIIa.

     

A gene for speed: contractile properties of isolated whole EDL muscle from an alpha-actinin-3 knockout mouse

The actin-binding protein -actinin-3 is one of the two isoforms of -actinin that are found in the Z-discs of skeletal muscle. -Actinin-3 is exclusively expressed in fast glycolytic muscle fibers. Homozygosity for a common polymorphism in the ACTN3 gene results in complete deficiency of -actinin-3 in about 1 billion individuals worldwide. Recent genetic studies suggest that the absence of -actinin-3 is detrimental to sprint and power performance in elite athletes and in the general population. In contrast, -actinin-3 deficiency appears to be beneficial for endurance athletes. To determine the effect of -actinin-3 deficiency on the contractile properties of skeletal muscle, we studied isolated extensor digitorum longus (fast-twitch) muscles from a specially developed -actinin-3 knockout (KO) mouse. -Actinin-3-deficient muscles showed similar levels of damage to wild-type (WT) muscles following lengthening contractions of 20% strain, suggesting that the presence or absence of -actinin-3 does not significantly influence the mechanical stability of the sarcomere in the mouse. -Actinin-3 deficiency does not result in any change in myosin heavy chain expression. However, compared with -actinin-3-positive muscles, -actinin-3-deficient muscles displayed longer twitch half-relaxation times, better recovery from fatigue, smaller cross-sectional areas, and lower twitch-to-tetanus ratios. We conclude that -actinin-3 deficiency results in fast-twitch, glycolytic fibers developing slower-twitch, more oxidative properties. These changes in the contractile properties of fast-twitch skeletal muscle from -actinin-3-deficient individuals would be detrimental to optimal sprint and power performance, but beneficial for endurance performance. extensor digitorum longus     

Functional overload increases beta-MHC promoter activity in rodent fast muscle via the proximal MCAT (betae3) site

Functional overload (OL)of the rat plantaris muscle by the removal of synergistic musclesinduces a shift in the myosin heavy chain (MHC) isoform expressionprofile from the fast isoforms toward the slow type I, or, -MHCisoform. Different length rat -MHC promoters were linked to afirefly luciferase reporter gene and injected in control and OLplantaris muscles. Reporter activities of 3,500, 914, 408, and215 bp promoters increased in response to 1 wk of OL. The smallest171 bp promoter was not responsive to OL. Mutation analyses ofputative regulatory elements within the 171 and 408 bp region wereperformed. The 408 bp promoters containing mutations of the e1,distal muscle CAT (MCAT; e2), CACC, or A/T-rich (GATA), were stillresponsive to OL. Only the proximal MCAT (e3) mutation abolished theOL response. Gel mobility shift assays revealed a significantly higherlevel of complex formation of the e3 probe with nuclear protein fromOL plantaris compared with control plantaris. These results suggestthat the e3 site functions as a putative OL-responsive element inthe rat -MHC gene promoter.

     

Duality of G protein-coupled mechanisms for beta-adrenergic activation of NKCC activity in skeletal muscle

Skeletal muscleNa⁺-K⁺-2Cl cotransporter (NKCC)activity provides a potential mechanism for regulated K⁺uptake. -Adrenergic receptor (-AR) activation stimulatesskeletal muscle NKCC activity in a MAPK pathway-dependent manner. Weexamined potential G protein-coupled pathways for -AR-stimulatedNKCC activity. Inhibition of G_s-coupled PKA blockedisoproterenol-stimulated NKCC activity in both the slow-twitch soleusmuscle and the fast-twitch plantaris muscle. However, thePKA-activating agents cholera toxin, forskolin, and 8-bromo-cAMP(8-BrcAMP) were not sufficient to activate NKCC in the plantaris andpartially stimulated NKCC activity in the soleus.Isoproterenol-stimulated NKCC activity in the soleus was abolished bypretreatment with pertussis toxin (PTX), indicating aG_i-coupled mechanism. PTX did not affect the8-BrcAMP-stimulated NKCC activity. PTX treatment also precluded theisoproterenol-mediated ERK1/2 MAPK phosphorylation in the soleus,consistent with NKCC's MAPK dependency. Inhibition ofisoproterenol-stimulated ERK activity by PTX treatment was associatedwith an increase in Akt activation and phosphorylation of Raf-1 on theinhibitory residue Ser²⁵⁹. These results demonstrate anovel, muscle phenotype-dependent mechanism for -AR-mediated NKCCactivation that involves both G_s and G_iprotein-coupled mechanisms.

     

Potassium depletion increases potassium clearance capacity in skeletal muscles in vivo during acute repletion

Muscular K uptake depends onskeletal muscle Na-K-ATPase concentration and activity. ReducedK uptake is observed in vitro in K-depleted rats. We evaluated skeletalmuscle K clearance capacity in vivo in rats K depleted for 14 days.[³H]ouabain binding, ₁ and₂ Na-K-ATPase isoform abundance, and K, Na, and Mgcontent were measured in skeletal muscles. Skeletal muscle K, Na, andMg and plasma K were measured in relation to intravenous KCl infusionthat continued until animals died, i.e., maximum KCl dose wasadministered. In soleus, extensor digitorum longus (EDL), andgastrocnemius muscles K depletion significantly reduced K content by18%, 15%, and 19%, [³H]ouabain binding by 36%, 41%,and 68%, and ₂ isoform abundance by 34%, 44%, and70%, respectively. No significant change was observed in₁ isoform abundance. In EDL and gastrocnemius muscles Kdepletion significantly increased Na (48% and 59%) and Mg (10% and17%) content, but only tendencies to increase were observed in soleusmuscle. K-depleted rats tolerated up to a fourfold higher KCl dose.This was associated with a reduced rate of increase in plasma K andincreases in soleus, EDL, and gastrocnemius muscle K of 56%, 42%, and41%, respectively, but only tendencies to increase in controls.However, whereas K uptake was highest in K-depleted animals, the Kuptake rate was highest in controls. In vivo K depletion is associatedwith markedly increased K tolerance and K clearance despitesignificantly reduced skeletal muscle Na-K-ATPase concentration. Theconcern of an increased risk for K intoxication during K repletionseems unwarranted.

     

Maintenance of muscle mass is not dependent on the calcineurin-NFAT pathway

In this study, the role of the calcineurinpathway in skeletal muscle atrophy and atrophy-reducing interventionswas investigated in rat soleus muscles. Because calcineurin has beensuggested to be involved in skeletal and cardiac muscle hypertrophy, we hypothesized that blocking calcineurin activity would eliminate beneficial effects of interventions that maintain muscle mass in theface of atrophy-inducing stimuli. Hindlimb suspension and spinal cordtransection were used to induce atrophy, and intermittent reloading andexercise were used to reduce atrophy. Cyclosporin (CsA, 25 mg · kg¹ · day¹) wasadministered to block calcineurin activity. Soleus muscles were studied14 days after the onset of atrophy. CsA administration did not inhibitthe beneficial effects of the two muscle-maintaining interventions, nordid it change muscle mass in control or atrophied muscles, suggestingthat calcineurin does not play a role in regulating muscle size duringatrophy. However, calcineurin abundance was increased in atrophiedsoleus muscles, and this was associated with nuclear localization ofNFATc1 (a nuclear factor of activated T cells). Therefore, resultssuggest that calcineurin may be playing opposing roles during skeletalmuscle atrophy and under muscle mass-maintaining conditions.

     

Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure

Congestive heart failure is characterized by a skeletal musclemyopathy with muscle bulk loss. The mechanisms responsible for thesechanges are not clear at present. We have investigated the role ofapoptosis in the rat "slow" soleus muscle during the developmentof heart failure, which was induced by injection of monocrotaline (30 mg/kg). We looked at the time course of apoptosis by studying sixanimals at each of the following time points: 0, 17, 24, and 30 days.We found a decreased expression of the antiapoptotic protein Bcl-2,which was accompanied by a rise of proapoptotic caspase-3. Ubiquitinlevels did not change. DNA nick-end labeling showed an increased numberof apoptotic nuclei both in myofibers and interstitial cells when heartfailure occurred. At variance with previous observations in thefast-twitch tibialis anterior muscle in the same animals, in whichtumor necrosis factor- (TNF-) increased at the time thatapoptosis occurred, the magnitude of apoptosis is lower in soleusmuscle and there is no appearance of muscle atrophy. In soleus muscle,apoptosis is accompanied by activation of the caspase-3 system. Thereis no activation of the TNF-- and ubiquitin-dependent protein waste.In conclusion, slow muscles are less prone to develop apoptosis thanfast muscles. Muscle atrophy appears earlier in these latter ones.

     

IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta

To elucidate signaling pathways activated by IL-1 and IL-6 that contribute to increased expression of plasminogen activator inhibitor-1 (PAI-1), we studied human hepatoma (HepG2) cells and primary mouse hepatocytes. HepG2 cell PAI-1 mRNA increased in response to IL-1, IL-6, and IL-1 plus IL-6 as shown by real-time PCR. Activity of the transiently transfected PAI-1 promoter (–829 to +36 bp) increased as well. Systematic promoter deletion assays showed that the region from –239 to –210 bp containing a putative CCAAT-enhancer binding protein (C/EBP) binding site was critical. Point mutations in this region abolished the IL-1 and IL-6 responses. Antibody interference electrophoretic mobility shift assays showed that C/EBP (but not C/EBP or C/EBP) binding and protein were increased by IL-1, IL-6, and IL-1 plus IL-6 in HepG2 cells. IL-1 and IL-6 increased expression of both PAI-1 mRNA and C/EBP mRNA in mouse primary hepatocytes as well. Downregulation of C/EBP induced with small interfering RNA (siRNA) decreased secretion of PAI-1. As judged from results obtained with inhibitors, signal transduction in all three of the mitogen-activated protein kinase pathways was involved in IL-1-inducible PAI-1 expression. By contrast, JAK signaling was responsible for the IL-6-induced inducible expression. Thus IL-1 and IL-6 exert directionally similar effects on PAI-1 expression, but the induction involves distinct signaling pathways with a final common mediator, C/EBP. CCAAT-enhancer binding protein; interleukin-1; interleukin-6; statins; thrombosis     

Skeletal muscle gene transfer: regeneration-associated deregulation of fast troponin I fiber type specificity

Direct genetransfer into skeletal muscle in vivo presents a convenientexperimental approach for studies of adult muscle gene regulatorymechanisms, including fast vs. slow fiber type specificity. Previous studies have reported preferentialexpression of fast myosin heavy chain and slow myosin light chain andtroponin I (TnIslow) gene constructs in muscles enriched in theappropriate fiber type. We now report a troponin I fast (TnIfast)direct gene transfer study. We injected into the mouse soleus muscleplasmid DNA or recombinant adenovirus carrying a TnIfast/-galactosidase (-gal) reporter construct that had previously beenshown to be expressed specifically in fast fibers in transgenic mice.Surprisingly, microscopic histochemical analysis 1 and 4 wkpostinjection showed similar TnIfast/-gal expression in fast andslow fibers. A low but significant level of muscle fiber segmentalregeneration was evident in muscles 1 wk postinjection, andTnIfast/-gal expression was preferentially targeted to regeneratingfiber segments. This finding can explain why TnIfast constructs arederegulated with regard to fiber type specificity, whereas the myosinconstructs previously studied are not. The involvement of regeneratingfiber segments in transduction by plasmid DNA and recombinantadenoviruses injected into intact normal adult muscle is anunanticipated factor that should be taken into account in the planningand interpretation of direct gene transfer experiments.

     

Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines

Cyclooxygenase-2 (COX-2) mediates various inflammatory responses and is expressed in pancreatic tissue from patients with chronic pancreatitis. To examine the role of COX-2 in chronic pancreatitis, we investigated its participation in regulating functions of pancreatic stellate cells (PSCs), using isolated rat PSCs. COX-2 was expressed in culture-activated PSCs but not in freshly isolated quiescent PSCs. TGF-1, IL-1, and IL-6 enhanced COX-2 expression in activated PSCs, concomitantly increasing the expression of -smooth muscle actin (-SMA), a parameter of PSC activation. The COX-2 inhibitor NS-398 blocked culture activation of freshly isolated quiescent PSCs. NS-398 also inhibited the enhancement of -SMA expression by TGF-1, IL-1, and IL-6 in activated PSCs. These data indicate that COX-2 is required for the initiation and promotion of PSC activation. We further investigated the mechanism by which cytokines enhance COX-2 expression in PSCs. Adenovirus-mediated expression of dominant negative Smad2/3 inhibited the increase in expression of COX-2, -SMA, and collagen-1 mediated by TGF-1 in activated PSCs. Moreover, dominant negative Smad2/3 expression attenuated the expression of COX-2 and -SMA enhanced by IL-1 and IL-6. Anti-TGF- neutralizing antibody also attenuated the increase in COX-2 and -SMA expression caused by IL-1 and IL-6. IL-6 as well as IL-1 enhanced TGF-1 secretion from PSCs. These data indicate that Smad2/3-dependent pathway plays a central role in COX-2 induction by TGF-1, IL-1, and IL-6. Furthermore, IL-1 and IL-6 promote PSC activation by enhancing COX-2 expression indirectly through Smad2/3-dependent pathway by increasing TGF-1 secretion from PSCs. transforming growth factor-; interleukin; Smad; autocrine; pancreatic fibrosis     

Response to caffeine and ryanodine receptor isoforms in mouse skeletal muscles

The response to caffeine was studied in mouse muscles[diaphragm, soleus, and extensor digitorum longus (EDL)] withdifferent ryanodine receptor isoform (RyR1, RyR3) composition and insingle permeabilized muscle fibers dissected from diaphragm ofwild-type (WT) and RyR3-deficient (RyR3/) mice at 1, 15, 30, and 60 postnatal days (PND). The caffeine response decreased duringdevelopment, and, in adult mice, was greater in diaphragm, lower inEDL, and intermediate in soleus. This suggests a direct relationbetween response to caffeine and RyR3 expression. The lack of RyR3reduced caffeine response in young, but not in adult mice, and did not abolish the age-dependent variation and the intermuscle differences. Indiaphragm single fibers, the response to caffeine increased duringdevelopment and was reduced in fibers lacking RyR3 both at 15 and 60 PND. A population of fibers highly responsive to caffeine was presentin adult WT and disappeared in RyR3/. The results confirm thecontribution of RyR3 to calcium release for contractile response andclarify the contribution of RyR3 to developmental changes andintermuscle differences.

     

Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-kappaB through phosphorylation of IkappaBbeta

Activation of NF-B requires the phosphorylation and degradation of its associated inhibitory proteins, IB. Previously, we reported that the extracellular signal-regulated kinase (ERK) is required for IL-1 to induce persistent activation of NF-B in cultured rat vascular smooth muscle cells (VSMCs). The present study examined the mechanism by which the ERK signaling cascade modulates the duration of NF-B activation. In cultured rat VSMCs, IL-1 activated ERK and induced degradation of both IB and IB, which was associated with nuclear translocation of both ribosomal S6 kinase (RSK)1 and NF-B p65. RSK1, a downstream kinase of ERK, was associated with an IB/NF-B complex, which was independent of the phosphorylation status of RSK1. Treatment of VSMCs with IL-1 decreased IB in the RSK1/IB/NF-B complex, an effect that was attenuated by inhibition of ERK activation. Knockdown of RSK1 by small interference RNA attenuated the IL-1-induced IB decrease without influencing ether ERK phosphorylation or the earlier IB degradation. By using recombinant wild-type and mutant IB proteins, both active ERK2 and RSK1 were found to directly phosphorylate IB, but only active RSK1 phosphorylated IB on Ser19 and Ser23, two sites known to mediate the subsequent ubiquitination and degradation. In conclusion, in the ERK signaling cascade, RSK1 is a key component that directly phosphorylates IB and contributes to the persistent activation of NF-B by IL-1. extracellular signal-regulated kinase; in vitro phosphorylation assay; recombinant proteins; small interference RNA; vascular smooth muscle cell     

Mechanical loading and injury induce human myotubes to release neutrophil chemoattractants

The purpose of this study was to 1) test the hypothesis that skeletal muscle cells (myotubes) after mechanical loading and/or injury are a source of soluble factors that promote neutrophil chemotaxis and superoxide anion (O₂^–·) production and 2) determine whether mechanical loading and/or injury causes myotubes to release cytokines that are known to influence neutrophil responses [tumor necrosis factor- (TNF-), IL-8, and transforming growth factor-1 (TGF-1)]. Human myotubes were grown in culture and exposed to either a cyclic strain (0, 5, 10, 20, or 30% strain) or a scrape injury protocol. Protocols of 5, 10, and 20% strain did not cause injury, whereas 30% strain and scrape injury caused a modest and a high degree of injury, respectively. Conditioned media from strained myotubes promoted chemotaxis of human blood neutrophils and primed them for O₂^–· production in a manner that was dependent on a threshold of strain and independent from injury. Neutrophil chemotaxis, but not priming, progressively increased with higher magnitudes of strain. Conditioned media only from scrape-injured myotubes increased O₂^–· production from neutrophils. Concentrations of IL-8 and total TGF-1 in conditioned media were reduced by mechanical loading, whereas TNF- and active TGF-1 concentrations were unaffected. In conclusion, skeletal muscle cells after mechanical loading and injury are an important source of soluble factors that differentially influence neutrophil chemotaxis and the stages of neutrophil-derived reactive oxygen species production. Neutrophil responses elicited by mechanical loading, however, did not parallel changes in the release of IL-8, TGF-1, or TNF- from skeletal muscle cells. inflammation; cytokines; exercise; free radicals     

Autocrine loop between TGF-beta1 and IL-1beta through Smad3- and ERK-dependent pathways in rat pancreatic stellate cells

Pancreatic stellate cells (PSCs) are activated during pancreatitis and promote pancreatic fibrosis by producing and secreting ECMs such as collagen and fibronectin. IL-1 has been assumed to participate in pancreatic fibrosis by activating PSCs. Activated PSCs secrete various cytokines that regulate PSC function. In this study, we have examined IL-1 secretion from culture-activated PSCs as well as its regulatory mechanism. RT-PCR and ELISA have demonstrated that PSCs express IL-1 mRNA and secrete IL-1 peptide. Inhibition of TGF-₁ activity secreted from PSCs by TGF-₁-neutralizing antibody attenuated IL-1 secretion from PSCs. Exogenous TGF-₁ increased IL-1 expression and secretion by PSCs in a dose-dependent manner. Adenovirus-mediated expression of dominant-negative (dn)Smad2/3 expression reduced both basal and TGF-₁-stimulated IL-1 expression and secretion by PSCs. Coexpression of Smad3 with dnSmad2/3 restored IL-1 expression and secretion by PSCs, which were attenuated by dnSmad2/3 expression. In contrast, coexpression of Smad2 with dnSmad2/3 did not alter them. Furthermore, inhibition of IL-1 activity secreted from PSCs by IL-1-neutralizing antibody attenuated TGF-₁ secretion from PSCs. Exogenous IL-1 enhanced TGF-₁ expression and secretion by PSCs. IL-1 activated ERK, and PD-98059, a MEK1 inhibitor, blocked IL-1 enhancement of TGF-₁ expression and secretion by PSCs. We propose that an autocrine loop exists between TGF-₁ and IL-1 in activated PSCs through Smad3- and ERK-dependent pathways. fibrosis; cytokine; chronic pancreatitis     

Colocalization but differential regulation of neuronal NO synthase and nicotinic acetylcholine receptor in C2C12 myotubes

In mammalian skeletal muscle,neuronal-type nitric oxide synthase (nNOS) is found to be enriched atneuromuscular endplates. Here we demonstrate the colocalization of thenicotinic acetylcholine receptor (nAChR, stained with -bungarotoxin)and nNOS (stained with a specific antibody) in murineC₂C₁₂ myotubes. However, coimmunoprecipitation experiments demonstrated no evidence for a direct protein-protein association between the nAChR and nNOS in C₂C₁₂myotubes. An antibody to the ₁-subunit of the nAChR didnot coprecipitate nNOS, and an nNOS-specific antibody did notprecipitate the ₁-subunit of the nAChR. Treatment ofmice with bacterial LPS downregulated the expression of nNOS inskeletal muscle, and treatment of C₂C₁₂ cellswith bacterial LPS and interferon- markedly decreased nNOS mRNA andprotein expression. In contrast, mRNA and protein of the nAChR (-,-, and -subunits) remained unchanged at the mRNA and proteinlevels. These data demonstrate that nNOS and the nAChR are colocalizedin murine skeletal muscle and C₂C₁₂ cells but differ in their expressional regulation.

     

L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure

Skeletal muscle in congestive heartfailure is responsible for increased fatigability and decreasedexercise capacity. A specific myopathy with increased expression offast-type myosins, myocyte atrophy, secondary to myocyteapoptosis triggered by high levels of circulating tumornecrosis factor- (TNF-) has been described. In an animal model ofheart failure, the monocrotaline-treated rat, we have observed anincrease of apoptotic skeletal muscle nuclei. Proapoptoticagents, caspase-3 and -9, were increased, as well as serum levels ofTNF- and its second messenger sphingosine. Treatment of rats withL-carnitine, known for its protective effect on musclemetabolism injuries, was found to inhibit caspases and to decrease thelevels of TNF- and sphingosine, as well as the number ofapoptotic myonuclei. Staurosporine was used in in vitro experimentsto induce apoptosis in skeletal muscle cells in culture. WhenL-carnitine was applied to skeletal muscle cells, before staurosporine treatment, we observed a reduction in apoptosis. These findings show that L-carnitine can preventapoptosis of skeletal muscles cells and has a role in thetreatment of congestive heart failure-associated myopathy.

     

Regulation of dihydropyridine receptor gene expression in mouse skeletal muscles by stretch and disuse

This study examined dihydropyridine receptor (DHPR) gene expression in mouse skeletal muscles during physiological adaptations to disuse. Disuse was produced by three in vivo models—denervation, tenotomy, and immobilization—and DHPR _1s mRNA was measured by quantitative Northern blot. After 14-day simultaneous denervation of the soleus (Sol), tibialis anterior (TA), extensor digitorum longus (EDL), and gastrocnemius (Gastr) muscles by sciatic nerve section, DHPR mRNA increased preferentially in the Sol and TA (+1.6-fold), whereas it increased in the EDL (+1.6-fold) and TA (+1.8-fold) after selective denervation of these muscles by peroneal nerve section. It declined in all muscles (–1.3- to –2.6-fold) after 14-day tenotomy, which preserves nerve input but removes mechanical tension. Atrophy was comparable in denervated and tenotomized muscles. These results suggest that factor(s) in addition to inactivity per se, muscle phenotype, or associated atrophy can regulate DHPR gene expression. To test the contribution of passive tension to this regulation, we subjected the same muscles to disuse by limb immobilization in a maximally dorsiflexed position. DHPR _1s mRNA increased in the stretched muscles (Sol, +2.3-fold; Gastr, +1.5-fold) and decreased in the shortened muscles (TA, –1.4-fold; EDL, –1.3-fold). The effect of stretch was confirmed in vitro. DHPR protein did not change significantly after 4-day immobilization, suggesting that additional levels of regulation may exist. These results demonstrate that DHPR _1s gene expression is regulated as an integral part of the adaptive response of skeletal muscles to disuse in both slow- and fast-twitch muscles and identify passive tension as an important signal for its regulation in vivo. dihydropyridine receptor mRNA; decreased use; passive tension; denervation; tenotomy; hindlimb immobilization